26 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Puxin Limited (NYSE: NEW) jumped 100.5% to $0.6016 after reporting results for the second quarter.
Victoria’s Secret Adopts $250M Accelerated Share Repurchase Program; Reaffirms Q4 Outlook
Victoria’s Secret & Co (NYSE:VSCO) has entered into an accelerated share repurchase agreement (ASR) with Goldman Sachs & Co LLC to…
Why Victoria’s Secret Shares Are Trading Higher Today
Victoria’s Secret & Co (NYSE: VSCO) is trading higher Wednesday morning after the company announced a $250 million accelerated share repurchase program and reaffirmed guidance.
10 Biggest Price Target Changes For Monday
Morgan Stanley cut Foot Locker, Inc. (NYSE: FL) price target from $66 to $47. Foot Locker shares fell 0.1% to $41.90 in pre-market trading.
Morgan Stanley Maintains Equal-Weight on Victoria’s Secret, Lowers Price Target to $54
Morgan Stanley analyst Kimberly Greenberger maintains Victoria's Secret (NYSE:VSCO) with a Equal-Weight and lowers the price target from $69 to $54.
54 Biggest Movers From Yesterday
Gainers
Longeveron Inc. (NASDAQ: LGVN) shares climbed 135.3% to close at $6.87 on Thursday. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.
Why Victoria’s Secret Shares Are Rising Today
Victoria’s Secret & Co (NYSE: VSCO) is trading significantly higher Thursday after the company announced better-than-expected third-quarter earnings results.
Mid-Afternoon Market Update: Dow Falls 75 Points; Dicerna Pharmaceuticals Shares Spike Higher
Toward the end of trading Thursday, the Dow traded down 0.21% to 35,855.96 while the NASDAQ rose 0.16% to 15,946.49. The S&P also rose, gaining 0.19% to 4,697.80.
44 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Longeveron Inc. (NASDAQ: LGVN) jumped 157% to $7.51. Longeveron said the FDA granted rare pediatric disease designation for the company’s Lomecel-B for the treatment of hypoplastic left heart syndrome.